TSHA (TSHA) Stock Price & Analysis
TSHA (TSHA) rose 0.54% to USD 5.6 as of September 8, 2026 at 06:56 UTC, according to Nexqual real-time market data.
TSHA last closed at USD 5.6; the session ranged USD 5.42–5.61 on volume of 2,111,279 shares. Market capitalization is —, with a 52-week range of USD 2.71–7.3 (NMS). Source: Nexqual, September 8, 2026 at 06:56 UTC.
Key Statistics (as of September 8, 2026 at 06:56 UTC)
| Price | USD 5.6 |
|---|---|
| Change | ▲ 0.54% (up) |
| Previous Close | USD 5.6 |
| Open | USD 5.6 |
| Day Range | USD 5.42 – 5.61 |
| 52-Week Range | USD 2.71 – 7.3 |
| Volume | 2,111,279 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (TSHA)
Nexqual's technical model rates TSHA "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:56 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.54 (neutral) |
| vs SMA50 | Below (USD 6.06) |
| MACD | -0.12 (negative) |
From TSHA's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | USD 3.76 | ▼ 0.79% |
| STTK | Shattuck Labs, Inc. | USD 6.79 | ▼ 1.74% |
| PRLD | Prelude Therapeutics Incorporat | USD 5.46 | ▲ 0.55% |
| FDMT | 4D Molecular Therapeutics, Inc. | USD 14.97 | ▲ 0.2% |
| ORIC | Oric Pharmaceuticals, Inc. | USD 12.86 | ▼ 2.06% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:56 UTC. This page is informational and not investment advice.